To ensure a focused analysis, several exclusion criteria were applied, including patients with end-stage renal disease (ESRD), acute heart failure exacerbation, ongoing urinary tract infection (UTI), myocardial infarction, alpha-1 antitrypsin deficiency, and those with a concurrent COVID-19 diagnosis. Here, PSMA6 is linked to stage 5 chronic kidney disease.